Clinical Trial Update: Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan [NA]

View source ↗

Summary

Clinical trial update for genomic-directed salvage chemotherapy in ovarian cancer comparing liposomal doxorubicin or topotecan; study terminated with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Topotecan (topotecan)
• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Ovarian Cancer | NA | Status: TERMINATED | Results posted: 2011-02-16